AV1 Arco Vara A.S.

Arco Vara AS korraldab 2023. aasta IV kvartali majandustulemuste tutvustamiseks veebiseminari

Arco Vara AS korraldab 2023. aasta IV kvartali majandustulemuste tutvustamiseks veebiseminari

Arco Vara kutsub kõiki huvilisi osalema veebiseminaril 15. veebruaril 2024 kell 10.00. Veebiseminar toimub eesti keeles.

Seminaril tutvustab 2023. aasta IV kvartali auditeerimata majandustulemusi grupi tegevjuht Miko-Ove Niinemäe.

Ülekanne toimub lingil:

Veebiseminar salvestatakse ning jääb avalikuks ettevõtte kodulehel.



Tiina Malm

Finantsjuht

Arco Vara AS





EN
13/02/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Arco Vara A.S.

 PRESS RELEASE

Decisions of the Annual General Meeting of shareholders of Arco Vara A...

Decisions of the Annual General Meeting of shareholders of Arco Vara AS The annual general meeting of shareholders of Arco Vara AS held on 9 May 2024 adopted the following decisions: To approve the annual report of Arco Vara AS for 2023.To allocate the net profit for the year ended on 31 December 2023 in the amount of 3,550 thousand EUR to retained earnings. To pay dividends to the shareholders 0.06 euros per share. The dividend will be paid out in 4 instalments as follows: 0.02 euros per share will be paid to the shareholders on 13 June 2024 by transfer to the shareholder's ban...

 PRESS RELEASE

Arco Vara ASi aktsionäride korralise üldkoosoleku otsused

Arco Vara ASi aktsionäride korralise üldkoosoleku otsused 09.05.2024 toimunud Arco Vara AS-i aktsionäride korraline üldkoosolek võttis vastu järgmised otsused: Kinnitada Arco Vara AS-i 2023. aasta majandusaasta aruanne.Kanda 31.12.2023 lõppenud majandusaasta puhaskasum summas 3550 tuhat eurot jaotamata kasumi hulka. Maksta dividendi 0,06 eurot aktsia kohta. Dividend makstakse välja 4 osas alljärgnevalt: 0,02 eurot aktsia kohta makstakse aktsionäridele 13.06.2024 ülekandega aktsionäri pangaarvele. Aktsionäride, kellel on õigus saada vastavat dividendi, nimekiri (record date) fiks...

 PRESS RELEASE

Change in the management of Arco Vara AS

Change in the management of Arco Vara AS Miko Niinemäe, Chairman of the Board at Arco Vara is to leave the company, and the Supervisory Board has begun searching for a new board member, who will take over the leadership by the end of the year at the latest. Miko Niinemäe, who joined Arco Vara in 2017 and was elected as the company's CEO in 2020, said he can leave with peace of mind. "Seven years in one organization is quite a long period these days. Starting as the youngest manager of a listed company on the Tallinn Stock Exchange, a career turn at some point is quite expected. I felt that...

 PRESS RELEASE

Arco Vara unaudited consolidated interim report for Q1 of 2024

Arco Vara unaudited consolidated interim report for Q1 of 2024 GROUP CEO’S REVIEW The beginning of the year was dominated by the European Central Bank's benchmark rate cut, aimed at bringing about economic revival. However, instead of relying on factors that are outside of our control, we should continue to realize completed and planned developments, assessing them realistically. In the first quarter, we were mainly engaged in the preparation of the sale of completed apartments of the Kodulahe development and the sale of Soodi 6 development. In addition, we have continued ...

 PRESS RELEASE

2024. aasta I kvartali konsolideeritud auditeerimata vahearuanne

2024. aasta I kvartali konsolideeritud auditeerimata vahearuanne JUHATAJA KOMMENTAARID Alanud aasta alguses on vedavaks teemaks keskpanga intressimäära langetamine, mis annab lootust majanduse aktiivsemaks muutumisele. Siiski ei tasu loota meist sõltumatute tegurite abile, vaid peame realistlikult hinnates jätkama valminud ja planeerimisel olevate arenduste realiseerimisega. Esimeses kvartalis tegelesime peamiselt Kodulahe valminud korterite müügi ja Soodi 6 arenduse müügi ettevalmistusega. Lisaks oleme jätkanud ehitustöödega Bulgaarias ja detailplaneeringu menetlusega ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch